Reaching Out in Cystic Fibrosis: Pharmacotherapy of Cystic Fibrosis and the Role of the Specialty Pharmacist

, ,
Pharmacy Times, July 2018 Digestive Health, Volume 84, Issue 7

FACULTY

Catherine B. Hobart, PharmD

PGY-2 Pediatric Pharmacy Resident The University of Arizona

Tucson, Arizona

Hanna Phan, PharmD, FCCP, FPPAG

Associate Professor, Department of Pharmacy Practice & Science

The University of Arizona — College of Pharmacy

Associate Professor, Department of Pediatrics The University of Arizona — College of Medicine

Associate Research Scientist

Asthma and Airway Disease Research Center The University of Arizona

Tucson, Arizona

MEDICAL WRITING AND EDITORIAL SUPPORT

Jeannette Y. Wick, RPh, MBA, FASCP

Assistant Director, Office of Pharmacy Professional Development

University of Connecticut School of Pharmacy

Storrs, Connecticut

EDUCATIONAL OBJECTIVES FOR PHARMACISTS

At the completion of this activity, the participant will be able to:

  • Identify opportunities to enhance prescribers’ practices and patient engagement in the chronic care of cystic fibrosis (CF)
  • Explore the role and place in therapy for the use of cystic fibrosis transmembrane conductance regulator (CFTR) modulating agents in the management of CF
  • Optimize strategies to engage persons with CF and their caregivers in sustaining daily care
  • Demonstrate the role of the pharmacist in CF medication management, including drug—drug interactions, optimizing medication efficacy, improving medication safety, and provider/ patient/caregiver education

TARGET AUDIENCE: Specialty, health-system, and community pharmacists; other health care professionals caring for patients with cystic fibrosis

ACTIVITY TYPE: Application

RELEASE DATE: July 13, 2018

EXPIRATION DATE: July 13, 2019

ESTIMATED TIME TO COMPLETE ACTIVITY: 3.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.